Genetics of depression: An overview of the current science

Issues in Mental Health Nursing

Volumn 32, Issue 4, 2011, Pages 192-202

  Elder, Betty L ^a   Mosack, Victoria ^a  

^a WICHITA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANTIDEPRESSANT AGENT;

ARTICLE; BRAIN; DRUG EFFECT; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; MAJOR DEPRESSION; NERVE TRACT; NURSING; PATHOPHYSIOLOGY; PHYSIOLOGY; TWINS;

ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER, MAJOR; DISEASES IN TWINS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEURAL PATHWAYS; NEUROTRANSMITTER AGENTS;

EID: 79952119639     PISSN: 01612840     EISSN: 10964673     Source Type: Journal    
DOI: 10.3109/01612840.2010.541588     Document Type: Article

References (59)

1. Aitchison, K. J., Basu, A., McGuffin, P., & Craig, I. (2005). Psychiatry and the "new genetics": Hunting for genes for behaviour and drug response. British Journal of Psychiatry, 186, 91-92. doi: 186/2/91 [pii] 10.1192/bjp. 186.2.91 (Pubitemid 40193774)
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: American Psychiatric Association.
3. Andres, A. M., de Hemptinne, C., & Bertranpetit, J. (2007). Heterogeneous rate of protein evolution in serotonin genes. Molecular Biological Evolution, 24(12), 2707-2715. doi: 10.1093/molbev/msm202
4. Belmaker, R. H., & Agam, G. (2008). Major depressive disorder. New England Journal of Medicine, 358(1), 55-68. doi: 358/1/55 [pii] 10.1056/NE-JMra073096
5. Blair, I. P., Mitchell, P. B., & Schofield, P. R. (2005). Techniques for the identification of genes involved in psychiatric disorders. Australian and New Zealand Journal of Psychiatry, 39, 542-549. (Pubitemid 41602538)
6. Bleakley, S. (2009). Review of choice and use of antidepressants. Progress in Neurology and Psychiatry, 13(1), 14-20. doi: DOI: 10.1002/pnp. 107
7. Boyer, E. W., & Shannon, M. (2005). The serotonin syndrome. New England Journal of Medicine, 352(11), 1112-1120. doi: 352/11/1112 [pii] 10.1056/NEJMra041867 (Pubitemid 40365352)
8. Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., et al. (2003). Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science, 301(5631), 386-389. doi: 10.1126/science.1083968 (Pubitemid 36877077)
9. Chiaroni, P., Azorin, J. M., Dassa, D., Henry, J. M., Giudicelli, S., Malthiery, Y., et al. (2000). Possible involvement of the dopamine D3 receptor locus in subtypes of bipolar affective disorder. Psychiatric Genetics, 10(1), 43-49. (Pubitemid 30345192)
10. Civelli, O., Bunzow, J., Albert, P., Van Tol, H., & Grandy, D. (1991). Molecular biology of the dopamine D2 receptor. NIDA Research Monographs, 111, 45-53.
11. Consensus Panel on Genetic/Genomic Nursing Competencies. (2009) Essentials of genetic and genomic nursing: Competencies, curricula guidelines, and outcome indicators (2nd ed.). Silver Springs, MD: American Nurses Association.
12. D'Souza, U., & Craig, I. (2006). Functional polymorphisms in dopamine and serotonin pathway genes. Human mutation, 27(1), 1-13. (Pubitemid 43045703)
13. Danese, A. (2008). Genetic opportunities for psychiatric epidemiology: On life stress and depression. Epidemiological Psichiatria Society, 17(3), 201-210.
14. Dong, C., Wong, M. L., & Licinio, J. (2009). Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: Association with major depression and antidepressant response in Mexican-Americans. Molecular Psychiatry, 14(12), 1105-1118. doi: mp200992 [pii] 10.1038/mp. 2009.92
15. Dunlop, B. W., & Nemeroff, C. B. (2007). The role of dopamine in the pathophysiology of depression. Archives of General Psychiatry, 64(3), 327-337. doi: 64/3/327 [pii] 10.1001/archpsyc.64.3.327 (Pubitemid 46376789)
16. Gizatullin, R., Zaboli, G., Jonsson, E. G., Asberg, M., & Leopardi, R. (2006). Haplotype analysis reveals tryptophan hydroxylase (TPH) 1 gene variants associated with major depression. Biological Psychiatry, 59(4), 295-300. doi: S0006-3223 (05) 00923-6 [pii] 10.1016/j.biopsych.2005.07.034 (Pubitemid 43238353)
17. Haeffel, G. J., Getchell, M., Koposov, R. A., Yrigollen, C. M., Deyoung, C. G., Klinteberg, B. A., et al. (2008). Association between polymorphisms in the dopamine transporter gene and depression: Evidence for a gene-environment interaction in a sample of juvenile detainees. Psychological Science, 19(1), 62-69. doi: PSCI2047 [pii] 10.1111/j.1467-9280.2008.02047.x
18. Joyce, P. R., McHugh, P. C., Light, K. J., Rowe, S., Miller, A. L., & Kennedy, M. A. (2009). Relationships between angry-impulsive personality traits and genetic polymorphisms of the dopamine transporter. Biological Psychiatry, 66(8), 717-721. doi: DOI: 10.1016/j.biopsych.2009.03.005
19. Kalia, M. (2005). Neurobiological basis of depression: An update. Metabolism, 54 (5, Supplement 1), 24-27. doi: DOI: 10.1016/j.metabol.2005.01.009 (Pubitemid 40546019)
20. Kato, T. (2007). Molecular genetics of bipolar disorder and depression. Psychiatry and Clinical Neuroscience, 61(1), 3-19. doi: PCN1604 [pii] 10.1111/j.1440-1819.2007.01604.x (Pubitemid 46089400)
21. Kendler, K. S., Gardner, C. O., Neale, M. C., & Prescott, C. A. (2001). Genetic risk factors for major depression in men and women: Similar or different heritabilities and same or partly distinct genes? Psychological Medicine, 31(4), 605-616. (Pubitemid 32421962)
22. Kendler, K. S., Thornton, L. M., & Gardner, C. O. (2001). Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. American Journal of Psychiatry, 158(4), 582-586. (Pubitemid 32289820)
23. Kobilka, B. K., & Deupi, X. (2007). Conformational complexity of G-proteincoupled receptors. Trends in Pharmacological Sciences, 28(8), 397-406. doi: 10.1016/j.tips.2007.06.003 (Pubitemid 47087966)
24. Krishnan, V., & Nestler, E. J. (2008). The molecular neurobiology of depression. Nature, 455(7215), 894-902. doi: nature07455 [pii] 10.1038/nature07455
25. Lanni, C., Govoni, S., Lucchelli, A., & Boselli, C. (2009). Depression and antidepressants: Molecular and cellular aspects. Cellular & Molecular Life Sciences, 66(18), 2985-3008. doi: 10.1007/s00018-009-0055-x
26. Lau, J. Y., & Eley, T. C. (2010). The genetics of mood disorders. Annual Review of Clinical Psychology, 6, 313-337. doi: 10.1146/annurev. clinpsy.121208.131308
27. Lea, D. H. (2008). Genetic and genomic healthcare: Ethical issues of importance to nurses. The Online Journal of Issues in Nursing, 13(1), 1-9.
28. Lea, D. H. (2009). Basic genetics and genomics: A primer for nurses. Online Journal of Issues in Nursing, 14(2), 1-13.
29. Leonardo, E. D., & Hen, R. (2006). Genetics of affective and anxiety disorders. Annual Review Psychology, 57, 117-137. doi: 10.1146/annurev. psych.57.102904.190118 (Pubitemid 43237229)
30. Lesch, K. P. (2004). Gene-environment interaction and the genetics of depression. Journal of Psychiatry & Neuroscience, 29(3), 174-184. (Pubitemid 38829854)
31. Levinson, D. F. (2006). The genetics of depression: A review. Biological Psychiatry, 60(2), 84-92. doi: S0006-3223 (05) 01013-9 [pii] 10.1016/j.biopsych.2005.08.024
32. Liang, Y., & Richelson, E. (2008). Triple reuptake inhibitors: Next-generation antidepressants. Primary Psychiatry, 15(4), 50-56. (Pubitemid 351556546)
33. Mann, J. J., Huang, Y. Y., Underwood, M. D., Kassir, S. A., Oppenheim, S., Kelly, T. M., et al. (2000). A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Archives of General Psychiatry, 57(8), 729-738. doi: yoa9309 [pii] (Pubitemid 30650106)
34. Maradiegue, A. (2008). A resource guide for learning about genetics. Online Journal of Issues in Nursing, 13(1), 10-10.
35. Marks, D. M., Pae, C. U., & Patkar, A. A. (2008). Triple reuptake inhibitors: The next generation of antidepressants. Current Neuropharmacology, 6(4), 338-343. doi: 10.2174/157015908787386078
36. Massat, I., Souery, D., Del-Favero, J., Nothen, M., Blackwood, D., Muir, W., et al. (2005). Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Molecular Psychiatry, 10(6), 598-605. doi: 4001615 [pii] 10.1038/sj.mp. 4001615 (Pubitemid 40897044)
37. Mill, J., & Petronis, A. (2007). Molecular studies of major depressive disorder: The epigenetic perspective. Molecular Psychiatry, 12(9), 799-814. doi: 4001992 [pii] 10.1038/sj.mp. 4001992 (Pubitemid 47347791)
38. Nakamura, K., & Hasegawa, H. (2007). Developmental role of tryptophan hydroxylase in the nervous system. Molecular Neurobiology, 35(1), 45-53. doi: 10.1007/bf02700623 (Pubitemid 47010927)
39. National Center for Biotechnology Information (NCBI). Retrieved February 26, 2010, from: http://www.ncbi.nlm.nih.gov
40. Nordquist, N., & Oreland, L. (2007). Monoallelic expression of MAO-A in skin fibroblasts. Journal of Neural Transmission, 114(6), 713-716. doi: 10.1007/s00702-007-0676-x (Pubitemid 46980473)
41. Online Mendelian Inheritance in Man, OMIM (TM). McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD). Retrieved February 26, 2010, from: http://www.ncbi.nlm.nih.gov/ omim
42. Perroud, N., Aitchison, K. J., Uher, R., Smith, R., Huezo-Diaz, P., Marusic, A., et al. (2009). Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology, 34(12), 2517-2528.
43. Pezawas, L., Meyer-Lindenberg, A., Goldman, A. L., Verchinski, B. A., Chen, G., Kolachana, B. S., et al. (2008). Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Molecular Psychiatry, 13(7), 709-716. Available: http://www.nature.com/mp/journal/v13/n7/suppinfo/ mp200832s1.html (Pubitemid 351861533)
44. Pinsonneault, J. K., Papp, A. C., & Sadee, W. (2006). Allelic mRNA expression of X-linked monoamine oxidase a (MAOA) inhuman brain: Dissection ofepigenetic and genetic factors. Human Molecular Genetics, 15(17), 2636-2649. doi: ddl192 [pii] 10.1093/hmg/ddl192 (Pubitemid 44288692)
45. Plomin, R., & Davis, O. S. (2009). The future of genetics in psychology and psychiatry: Microarrays, genome-wide association, and non-coding RNA. Journal of Child Psychology & Psychiatry, 50 (1-2), 63-71. doi: JCPP1978 [pii] 10.1111/j.1469-7610.2008.01978.x
46. Raison, C. L., Capuron, L., & Miller, A. H. (2006). Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends in Immunology, 27(1), 24-31. doi: S1471-4906 (05) 00288-7 [pii] 10.1016/j.it.2005.11.006 (Pubitemid 43083561)
47. Sadock, B., & Sadock, V. (2007). Kaplan & Sadock's synopsis of psychiatry: Behavioral sciences/clinical psychiatry (10th ed.). Philadelphia, PA: Lippincott Williams & Wilkins.
48. Schinka, J. A., Busch, R. M., & Robichaux-Keene, N. (2004). A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Molecular Psychiatry, 9(2), 197-202. doi: 10.1038/sj.mp. 4001405 4001405 [pii] (Pubitemid 38299534)
49. Schotte, C. K., Van den Bossche, B., De Doncker, D., Claes, S., & Cosyns, P. (2006). A biopsychosocial model as a guide for psychoeducation and treatment of depression. Depression & Anxiety, 23(5), 312-324. doi: 10.1002/da.20177 (Pubitemid 44414694)
50. Shimosawa, T., Takano, K., Ando, K., & Fujita, T. (2004). Magnesium inhibits norepinephrine release by blocking n-type calcium channels at peripheral sympathetic nerve endings. Hypertension, 44(6), 897-902. doi: 10.1161/01.hyp. 0000146536.68208.84 (Pubitemid 39577418)
51. Stahl, S. M. (2008). Stahl's essential psychopharmacology (3rd ed.). New York, NY: Cambridge University Press.
52. Stone, E. A., Lin, Y., & Quartermain, D. (2008). A final common pathway for depression? Progress toward a general conceptual framework. Neuroscience & Biobehavioral Reviews, 32(3), 508-524. doi: S0149-7634 (07) 00113-3 [pii] 10.1016/j.neubiorev. 2007.08.007 (Pubitemid 351173335)
53. Sullivan, P. F. (2010). Sullivan lab evidence project. Retrieved from https://slep. unc.edu/evidence/
54. Sullivan, P. F., Neale, M. C., & Kendler, K. S. (2000). Genetic epidemiology of major depression: Review and meta-analysis. American Journal of Psychiatry, 157(10), 1552-1562.
55. Szegedi, A., Rujescu, D., Tadic, A., Muller, M. J., Kohnen, R., Stassen, H. H., et al. (2005). The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression. Pharmacogenomics Journal, 5(1), 49-53. doi: 6500289 [pii] 10.1038/sj.tpj.6500289 (Pubitemid 40220617)
56. Uher, R., Huezo-Diaz, P., Perroud, N., Smith, R., Rietschel, M., Mors, O., et al. (2009). Genetic predictors of response to antidepressants in the GEN-DEP project. Pharmacogenomics Journal, 9(4), 225-233. doi: tpj200912 [pii] 10.1038/tpj.2009.12
57. Visscher, P. M., Hill, W. G., & Wray, N. R. (2008). Heritability in the genomics era-concepts and misconceptions. Nature Reviews Genetics, 9(4), 255-266. doi: nrg2322 [pii] 10.1038/nrg2322 (Pubitemid 351399832)
58. World Health Organization. (2010). Depression. Retrieved from http://www.who.int/mental-health/management/depression/definition/en/
59. Zhang, X., Gainetdinov, R. R., Beaulieu, J. M., Sotnikova, T. D., Burch, L. H., Williams, R. B., et al. (2005). Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron, 45(1), 11-16. doi: S0896627304008086 [pii] 10.1016/j.neuron. 2004.12.014 (Pubitemid 40075345)